About medartis holding ag - MDRSF
Medartis Holding AG engages in the development, manufacture, and sale of medical devices for surgical fixation of bone fractures. It operates through the following geographical segments: EMEA, US, APAC, and LATAM. The company was founded by Thomas Straumann on November 3, 1997 and is headquartered in Basel, Switzerland.
MDRSF At a Glance
Medartis Holding AG
Hochbergerstrasse 60E
Basel, Basel-Stadt (Basle Town) 4057
| Phone | 41-61-633-34-34 | Revenue | 235.92M | |
| Industry | Medical Specialties | Net Income | 688.81K | |
| Sector | Health Technology | 2023 Sales Growth | 23.241% | |
| Fiscal Year-end | 12 / 2024 | Employees | 876 | |
| View SEC Filings |
MDRSF Valuation
| P/E Current | 211.162 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 1,772.72 |
| Price to Sales Ratio | 5.175 |
| Price to Book Ratio | 4.072 |
| Price to Cash Flow Ratio | 54.958 |
| Enterprise Value to EBITDA | 34.379 |
| Enterprise Value to Sales | 5.26 |
| Total Debt to Enterprise Value | 0.04 |
MDRSF Efficiency
| Revenue/Employee | 269,310.088 |
| Income Per Employee | 786.312 |
| Receivables Turnover | 4.283 |
| Total Asset Turnover | 0.613 |
MDRSF Liquidity
| Current Ratio | 3.077 |
| Quick Ratio | 1.591 |
| Cash Ratio | 0.548 |
MDRSF Profitability
| Gross Margin | 71.489 |
| Operating Margin | 5.396 |
| Pretax Margin | 1.116 |
| Net Margin | 0.292 |
| Return on Assets | 0.179 |
| Return on Equity | 0.246 |
| Return on Total Capital | 0.195 |
| Return on Invested Capital | 0.211 |
MDRSF Capital Structure
| Total Debt to Total Equity | 16.539 |
| Total Debt to Total Capital | 14.192 |
| Total Debt to Total Assets | 12.064 |
| Long-Term Debt to Equity | 13.888 |
| Long-Term Debt to Total Capital | 11.917 |